R3 Clinical Acquires Exclusive Rights to Laboratory Skin Care Series
LAS VEGAS, April 25, 2012 /PRNewswire-iReach/ -- R3 Clinical (www.r3clinical.com) today announced it has signed an agreement with Cellaboratories Research and Investment (http://www.lfintlgroup.com) making R3 Clinical the exclusive Distributor for North America. This agreement will showcase an exceptional Skin Care line that has never been available in North America.
"After extensive negotiations and research, we decided to enter in to this long term partnership with Cellaboratories Research and Investment that will give us access to a top line Skin Care product, along with being their partner, we will play an important role in developing new products for the North American market," said Stephen Brown, CEO of R3 Clinical.
"R3 Clinical is a perfect partner for us and after many conversations with Mr. Brown we felt very comfortable with the direction that R3 Clinical was going to take the product line," said Leon Low the head of Business Development. "We look forward to providing R3 Clinical with a great competitive edge by delivering a premium product that has never been available to the North American market." Said Leon Low the head of Business Development.
The 5 step Skin Care series has Age-Defying Essentials and a simple regenerating system that helps to defend your skin against the external environment while significantly diminishes signs of aging. Its PhytoCellular Formula repairs your skin by stimulating the cells renewal within and promotes the synthesis of collagen thus facilitating the rejuvenation of your skin to regain its radiance, firmness and youthfulness. Starting from today, allow your complexion to exude that perfect glow with the delivery of a firmer and fresher looking skin.
About R3 Clinical:
A company formed specifically to acquire elite Beauty products from around the world that have never been made available to the North American market. In addition R3 Clinical matches its products with top name celebrities that will present the products in a definitive and professional approach.
About Cellaborarories Research & Investment:
Incorporated in 2006, LFI Group is one of the fastest growing network companies headquartered in Singapore and supported by numerous affiliates and offices all around the world. Since its inception, the Group has constantly seeks to expand its product line under its LF brandings to target the different market segments. They include TCM naturopathy products under Long Far, anti-aging products under Laboratory Formula, technological products under Linac Fusion. Every product under the Group benefits from considerable investments in product development and state-of-the art facilities operate in strict accordance to the rigorous quality management standards and industry benchmarks for excellence.
For more information, contact:
Stephen Brown, (702) 4o6-5100, firstname.lastname@example.org
Cellaboratories Research & Investment:
Leon Low, 011(65) 6842 4329 email@example.com
Media Contact: STEPHEN BROWN R3 Clinical, Inc, 702-406-5100, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE R3 Clinical, IncBack to top